Food and Drug Administration

Condividi contenuti
Aggiornato: 16 ore 54 min fa

Coronavirus (COVID-19) Update: July 23, 2021

Ven, 23/07/2021 - 22:04
Coronavirus (COVID-19) Update: July 23, 2021
Categorie: Istituzioni

Coronavirus (COVID-19) Update: July 20, 2021

Mar, 20/07/2021 - 22:35
Coronavirus (COVID-19) Update: July 20, 2021
Categorie: Istituzioni

Coronavirus (COVID-19) Update: July 16, 2021

Ven, 16/07/2021 - 22:28
Coronavirus (COVID-19) Update
Categorie: Istituzioni

FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

Gio, 15/07/2021 - 19:49
The FDA fully approved a drug intended to treat lymphoma in dogs, making the drug the first conditionally approved new animal drug for dogs to achieve full FDA approval.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: July 13, 2021

Mar, 13/07/2021 - 22:51
Coronavirus (COVID-19) Update: July 13, 2021
Categorie: Istituzioni

Coronavirus (COVID-19) Update: July 9, 2021

Ven, 09/07/2021 - 21:44
Coronavirus (COVID-19) Update: July 9, 2021
Categorie: Istituzioni

Joint CDC and FDA Statement on Vaccine Boosters

Ven, 09/07/2021 - 21:18
Joint CDC and FDA Statement on Vaccine Boosters
Categorie: Istituzioni

FDA In Brief: FDA Issues Systems Recognition Draft Guidance

Ven, 09/07/2021 - 19:09
This draft guidance explains how the agency plans to adjust its regulatory oversight activities for foods subject to FDA regulatory requirements when the foods are produced in or imported from other countries.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: July 6, 2021

Mar, 06/07/2021 - 21:57
Coronavirus (COVID-19) Update: July 6, 2021
Categorie: Istituzioni

Coronavirus (COVID-19) Update: July 2, 2021

Ven, 02/07/2021 - 21:12
Coronavirus (COVID-19) Update
Categorie: Istituzioni

FDA Releases Cyclospora Prevention, Response and Research Action Plan

Gio, 01/07/2021 - 20:27
As part of our ongoing efforts to combat foodborne illness, the FDA released the Cyclospora Prevention, Response and Research Action Plan
Categorie: Istituzioni

FDA Approves Component of Treatment Regimen for Most Common Childhood Cancer

Gio, 01/07/2021 - 00:27
The FDA approved a drug as a component of a chemotherapy regimen to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients who are allergic to the E. coli-derived asparaginase products used most commonly for treatment.
Categorie: Istituzioni

FDA In Brief: FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems as Access to N95s Increases Nationwide

Mer, 30/06/2021 - 22:31
FDA announced it is revoking EUAs of all non-NIOSH-approved disposable respirators, which includes imported disposable respirators such as KN95s, along with revoking EUAs for decontamination and bioburden reduction systems.
Categorie: Istituzioni

FDA Provides Update on Ongoing Efforts to Better Understand the Occurrence of PFAS in the Food Supply

Mer, 30/06/2021 - 17:10
FDA Provides Update on Ongoing Efforts to Better Understand the Occurrence of PFAS in the Food Supply
Categorie: Istituzioni

Coronavirus (COVID-19) Update: June 29, 2021

Mar, 29/06/2021 - 22:28
The FDA has sent to Congress its Report on Drug Shortages for Calendar Year 2020, which includes a section on the agency’s drug shortage efforts in response to COVID-19. The FDA is also working to implement the drug shortage-related provisions of the Coronavirus Aid, Relief, & Economic Security Act.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: June 25, 2021

Sab, 26/06/2021 - 01:44
Coronavirus (COVID-19) Update
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19

Ven, 25/06/2021 - 00:56
The FDA authorized a drug for the treatment for the treatment of COVID-19 in hospitalized adults and pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Categorie: Istituzioni

FDA In Brief: FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies

Gio, 24/06/2021 - 15:53
FDA released new draft guidance encouraging broadening clinical trials eligibility criteria to include patients with incurable cancers, regardless of prior therapies.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: June 22, 2021

Mar, 22/06/2021 - 21:13
The FDA issued a Drug Safety Communication for hand sanitizers, warning that symptoms such as headache, nausea, and dizziness can occur after applying alcohol-based hand sanitizers to the skin and inhaling the vapors that linger; and issued a warning letter to a company selling an unapproved product
Categorie: Istituzioni

FDA Approves First Oral Blood Thinning Medication for Children

Lun, 21/06/2021 - 21:57
Today, the FDA approved Pradaxa oral pellets and capsules to treat children with blood clots directly after they have been treated with a blood thinner given by injection for at least five days, and to prevent recurrent clots among patients who completed treatment for their first clot.
Categorie: Istituzioni